Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W S Mulcahy

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Therapeutics|September 1, 1993
Large prospective study of ramipril in patients with hypertension. CARE InvestigatorsN M Kaplan, L E Sproul, W S Mulcahy
Journal of Immunoassay|January 1, 1987
Radioimmunoassays for the enantiomeric components of indacrinone and their phenolic metabolitesK P Vyas, M Hichens, W S Mulcahy, et al.
Nephron|January 1, 1990
Long-term renal effects of enalapril therapy in patients with renal insufficiencyR D Smith, P V Rodel, W S Mulcahy, et al.
Kidney International. Supplement|April 1, 1991
Hyperlipidemia and progressive renal diseaseW F Keane, W S Mulcahy, B L Kasiske, et al.
Journal of the American Society of Nephrology : JASN|April 1, 1995
The study of the effect of intensity of blood pressure management on the progression of type 1 diabetic nephropathy: study design and baseline patient characteristics. Collaborative Study GroupR A Rodby, R Rohde, J Evans, et al.
Clinical Therapeutics|January 1, 1993
Double-blind, placebo-controlled study of ramipril in diabetics with mild to moderate hypertensionS L Schwartz, C Hanson, C Lucas, et al.
Medical Toxicology and Adverse Drug Experience|March 1, 1989
Tolerability of long term therapy with enalapril maleate in patients resistant to other therapies and intolerant to captoprilE J Rucinska, R Small, W S Mulcahy, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Therapeutics|September 1, 1993
Large prospective study of ramipril in patients with hypertension. CARE InvestigatorsN M Kaplan, L E Sproul, W S Mulcahy
Journal of Immunoassay|January 1, 1987
Radioimmunoassays for the enantiomeric components of indacrinone and their phenolic metabolitesK P Vyas, M Hichens, W S Mulcahy, et al.
Nephron|January 1, 1990
Long-term renal effects of enalapril therapy in patients with renal insufficiencyR D Smith, P V Rodel, W S Mulcahy, et al.
Kidney International. Supplement|April 1, 1991
Hyperlipidemia and progressive renal diseaseW F Keane, W S Mulcahy, B L Kasiske, et al.
Journal of the American Society of Nephrology : JASN|April 1, 1995
The study of the effect of intensity of blood pressure management on the progression of type 1 diabetic nephropathy: study design and baseline patient characteristics. Collaborative Study GroupR A Rodby, R Rohde, J Evans, et al.
Clinical Therapeutics|January 1, 1993
Double-blind, placebo-controlled study of ramipril in diabetics with mild to moderate hypertensionS L Schwartz, C Hanson, C Lucas, et al.
Medical Toxicology and Adverse Drug Experience|March 1, 1989
Tolerability of long term therapy with enalapril maleate in patients resistant to other therapies and intolerant to captoprilE J Rucinska, R Small, W S Mulcahy, et al.
Pageof 1